home / stock / rlftf / rlftf quote
Last: | $1.45 |
---|---|
Change Percent: | -1.4% |
Open: | $1.45 |
Close: | $1.45 |
High: | $1.45 |
Low: | $1.35 |
Volume: | 579 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.45 | $1.45 | $1.45 | $1.45 | $1.35 | 579 | 04-19-2024 |
$1.43 | $1.35 | $1.43 | $1.43 | $1.35 | 3,806 | 04-18-2024 |
$1.4 | $1.3 | $1.4 | $1.4 | $1.2 | 1,327 | 04-17-2024 |
$1.35 | $1.35 | $1.35 | $1.5 | $1.3 | 3,523 | 04-16-2024 |
$1.32 | $1.325 | $1.32 | $1.45 | $1.2 | 1,011 | 04-15-2024 |
$1.45 | $1.35 | $1.45 | $1.45 | $1.34 | 2,212 | 04-12-2024 |
$1.45 | $1.45 | $1.45 | $1.45 | $1.45 | 183 | 04-11-2024 |
$1.5 | $1.5 | $1.5 | $1.5 | $1.456 | 829 | 04-10-2024 |
$1.45 | $1.5 | $1.45 | $1.5 | $1.43 | 1,491 | 04-09-2024 |
$1.4528 | $1.4528 | $1.4528 | $1.4528 | $1.4528 | 208 | 04-08-2024 |
$1.5 | $1.45 | $1.5 | $1.5 | $1.45 | 4,894 | 04-05-2024 |
$1.43 | $1.53 | $1.43 | $1.53 | $1.34 | 7,143 | 04-04-2024 |
$1.375 | $1.375 | $1.375 | $1.375 | $1.375 | 217 | 04-03-2024 |
$1.45 | $1.45 | $1.45 | $1.45 | $1.41 | 3,333 | 04-02-2024 |
$1.44 | $1.45 | $1.44 | $1.45 | $1.39 | 1,567 | 04-01-2024 |
$1.45 | $1.51 | $1.45 | $1.51 | $1.41 | 6,261 | 03-29-2024 |
$1.45 | $1.51 | $1.45 | $1.51 | $1.41 | 6,261 | 03-28-2024 |
$1.55 | $1.58 | $1.55 | $1.58 | $1.4018 | 1,215 | 03-27-2024 |
$1.56 | $1.43 | $1.56 | $1.66 | $1.43 | 11,552 | 03-26-2024 |
$1.64 | $1.65 | $1.64 | $1.65 | $1.55 | 1,378 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Mondobiotech Holding AG Basel Company Name:
RLFTF Stock Symbol:
OTCMKTS Market:
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call p...
GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announce...
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call point Transaction is expected to be accretive to 2024 earnings Estimated peak sales of more than $10 million annually U.S. phenylketonuria ("PKU"...